CORT
Corcept Therapeutics Inc
Price:  
34.38 
USD
Volume:  
554,413.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CORT WACC - Weighted Average Cost of Capital

The WACC of Corcept Therapeutics Inc (CORT) is 7.1%.

The Cost of Equity of Corcept Therapeutics Inc (CORT) is 9.90%.
The Cost of Debt of Corcept Therapeutics Inc (CORT) is 5.00%.

Range Selected
Cost of equity 8.50% - 11.30% 9.90%
Tax rate 14.00% - 16.60% 15.30%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.4% - 7.7% 7.1%
WACC

CORT WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.01 1.14
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.50% 11.30%
Tax rate 14.00% 16.60%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.4% 7.7%
Selected WACC 7.1%